Top Abstract Purchase Related
Home
>
Node
>
Subnode

Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia

Ockelford, P.A.; Menon, N.C.; Berry, E.W.

New Zealand Medical Journal 92(672): 375-378

1980

ISSN/ISBN: 0028-8446
PMID: 6970907
Document Number: 161658
The use of 1 deamino-8-D-arginine vasopressin (DDVAP), is reported in seven patients with von Willebrand's disease and mild haemophilia undergoing elective surgery. There were no haemorrhagic complications, and both the quality of the clot formed and the rate of healing appeared entirely normal in all patients. No patient received blood products. Local burning pain due to paravenous leakage at the infusion site in a single patient, and transient facial flushing in another were the only side effects encountered. In addition to the anticipated rise in F.VIII:C and F.VIIIR:Ag, shortening of the bleeding time was observed in all five patients with von Willebrand's disease receiving DDAVP. Three additional patients who received intranasal DDAVP showed an inconsistent response in the laboratory parameters measured.

Document emailed within 1 workday
Secure & encrypted payments

Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S. 1985: Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP Ugeskrift for Laeger 147(45): 3592-3594
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063
Derkx, F.H.; Man in 't Veld, A.J.; Jones, R.; Reid, J.L.; Schalekamp, M.A. 1983: DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(2): 58-61
Lumholtz, I.B. 1977: Drug information. Therapeutic main group: antidiuretics. Preparation DDAVP (deamino arginine vasopressin); Minurin, Lypressinum; Insipid retard; Vasopressin Sygeplejersken 77(30): 21
Somerfield, S.D.; Hocken, A.G. 1977: Desamino arginine vasopressin (DDAVP) as a diagnostic agent New Zealand Medical Journal 86(600): 472-473
Brink, H.S.; Derkx, F.H.; Boomsma, F.; Brommer, E.J.; Schalekamp, M.A. 1993: 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus Netherlands Journal of Medicine 43(1-2): 5-12
Limal, J.M.; Mugner, E.; Czernichow, P. 1977: Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin) Archives Francaises de Pediatrie 34(10): 965-972
Köhler, M.; Hellstern, P.; Miyashita, C.; von Blohn, G.; Wenzel, E. 1986: Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP) Thrombosis and Haemostasis 55(1): 108-111
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Dubrovina, N.I.; Papsuevich, O.S.; Chipens, G.I. 1991: The slowing of the extinction of a conditioned reaction and the antiamnesic action of arginine vasopressin and des-glycine-(8-arginine) vasopressin Farmakologiia i Toksikologiia 54(5): 5-7
Henneberry, H.P.; Slater, J.D.; Eisen, V.; Führ, S. 1992: Arginine vasopressin response to hypertonicity in hypertension studied by arginine vasopressin assay in unextracted plasma Journal of Hypertension 10(3): 221-228
Sultan, Y.; Loyer, F.; Venot, A. 1992: Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease Nouvelle Revue Francaise D'hematologie 34(1): 55-60
Czaja, M.; Kruszyński, M.; Hinko, A.; Soloff, M.S. 1994: Arginine vasopressin antagonism of oxytocin-stimulated PGE2 release from rabbit amnion cells and the activities of thioanalogs of oxytocin and arginine vasopressin Polish Journal of Pharmacology 46(5): 429-437
Schinco, P.M.; Rizza, C.R. 1983: Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease Haematologica 68(1): 124-134
DeVore, G.R.; Mahoney, M.J.; Hobbins, J.C. 1980: Antenatal diagnosis of haemoglobinopathies, haemophilia, von Willebrand's disease, Duchenne's muscular dystrophy, and chronic granulomatous disease by fetal blood analysis Clinics in Obstetrics and Gynaecology 7(1): 41-72
Kreuz, W.; Auerswald, G.; Brückmann, C.; Zieger, B.; Linde, R.; Funk, M.; Auberger, K.; Sutor, A.H.; Rasshofer, R.; Roggendorf, M. 1992: Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease Thrombosis and Haemostasis 67(1): 184
Takase, T.; Nishino, M.; Yasui, M.; Shima, M.; Yoshikawa, N.; Fukui, H. 1985: Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia a and von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(7): 1571-1578
Nordmann, A. 1998: Mild von type i von Willebrand disease Praxis 87(21): 747-748
Ebenezer, I.S. 1994: The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors Methods and Findings in Experimental and Clinical Pharmacology 16(5): 315-321